Although the revenue and EPS for Inogen (INGN) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall ...
Inogen posted a Q4 adjusted EPS loss of $0.24, beating estimates, with sales reaching $80.1 million versus the $73.9 million consensus. The company expects FY25 revenue of $352 million-$355 ...
Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results